1. Home
  2. JCSE vs CDT Comparison

JCSE vs CDT Comparison

Compare JCSE & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCSE
  • CDT
  • Stock Information
  • Founded
  • JCSE 1999
  • CDT 2019
  • Country
  • JCSE Singapore
  • CDT United States
  • Employees
  • JCSE N/A
  • CDT N/A
  • Industry
  • JCSE Miscellaneous manufacturing industries
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • JCSE Consumer Discretionary
  • CDT Health Care
  • Exchange
  • JCSE Nasdaq
  • CDT Nasdaq
  • Market Cap
  • JCSE 5.9M
  • CDT 5.2M
  • IPO Year
  • JCSE 2022
  • CDT N/A
  • Fundamental
  • Price
  • JCSE $0.90
  • CDT $1.64
  • Analyst Decision
  • JCSE
  • CDT
  • Analyst Count
  • JCSE 0
  • CDT 0
  • Target Price
  • JCSE N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • JCSE 10.5K
  • CDT 95.0K
  • Earning Date
  • JCSE 05-15-2025
  • CDT 08-26-2025
  • Dividend Yield
  • JCSE 9.99%
  • CDT N/A
  • EPS Growth
  • JCSE N/A
  • CDT N/A
  • EPS
  • JCSE 0.00
  • CDT N/A
  • Revenue
  • JCSE $14,126,397.00
  • CDT N/A
  • Revenue This Year
  • JCSE N/A
  • CDT N/A
  • Revenue Next Year
  • JCSE N/A
  • CDT N/A
  • P/E Ratio
  • JCSE $195.99
  • CDT N/A
  • Revenue Growth
  • JCSE 6.92
  • CDT N/A
  • 52 Week Low
  • JCSE $0.86
  • CDT $1.61
  • 52 Week High
  • JCSE $2.39
  • CDT $274.80
  • Technical
  • Relative Strength Index (RSI)
  • JCSE 34.60
  • CDT 29.41
  • Support Level
  • JCSE $1.04
  • CDT $1.66
  • Resistance Level
  • JCSE $1.00
  • CDT $1.85
  • Average True Range (ATR)
  • JCSE 0.04
  • CDT 0.11
  • MACD
  • JCSE -0.01
  • CDT 0.03
  • Stochastic Oscillator
  • JCSE 0.00
  • CDT 8.36

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: